UPPSALA, Sweden , and SUNNYVALE, Calif. , Oct. 4, 2021 /PRNewswire/ -- C-RAD AB (NASDAQ Stockholm: CRAD B) and Accuray Incorporated (NASDAQ: ARAY) announced today they have signed an agreement designed to enhance the Accuray Radixact ® System's ability to treat breast cancer.
More than 30 Accuray TomoTherapy® and CyberKnife® Platform Systems Are Currently in Use at Unicancer, the Largest Network of Comprehensive Cancer Centers in Europe SUNNYVALE, Calif. , Sept. 29, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Unicancer has selected
SUNNYVALE, Calif. , Sept. 23, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Nagoya City University Hospital in Aichi has treated the first cancer patient in Japan using the Radixact ® System with ClearRT ™ helical fan-beam kVCT imaging.
- Prospective, randomized, international multicenter study - PACE - Prostate Advances in Comparative Evidence - results presented at ESTRO 2021 - Bladder side effects were experienced half as often with CyberKnife SBRT as with conventional linear accelerator delivered SBRT two years after treatment
SUNNYVALE, Calif. , Aug. 23, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Mika Nishimura to the company's Board of Directors, effective as of August 17, 2021 . With Ms. Nishimura's appointment, the Accuray Board will consist of nine members. Ms.
SUNNYVALE, Calif. , Aug. 11, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2021 . Q4 Fiscal 2021 and Recent Operating Highlights Gross orders of $112.7 million , an increase of 19 percent from the
ClearRT Significantly Improves Image Quality, Facilitating the Delivery of More Precise and Accurate Treatments to Patients SUNNYVALE, Calif. , July 22, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the medical care team at Hong Kong Sanatorium & Hospital (HKSH) in
SUNNYVALE, Calif. , July 14, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2021, ended June 30, 2021 , after the market close on Wednesday, August 11, 2021. Management will host a conference call to review the results
- UW-Madison School of Veterinary Medicine performed the first-in-world treatment - Renowned veterinary school leveraged the advanced Radixact and Synchrony technology, currently available at top academic hospitals, to provide the highest level of care SUNNYVALE, Calif.
SUNNYVALE, Calif. , June 22, 2021 /PRNewswire/ -- Accuray (NASDAQ: ARAY) announced today that Suzanne Winter has been promoted to president, effective as of July 1, 2021 . Ms. Winter , who previously served as the company's chief commercial officer and senior vice president of R&D and medical and
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.